Latest Insider Transactions at Apellis Pharmaceuticals, Inc. (APLS)
This section provides a real-time view of insider transactions for Apellis Pharmaceuticals, Inc. (APLS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Apellis Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Apellis Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 05
2023
|
Timothy Eugene Sullivan Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
69,779
+32.12%
|
$697,790
$10.03 P/Share
|
|
Jun 01
2023
|
Karen Lewis Chief People Officer |
SELL
Open market or private sale
|
Direct |
5,000
-10.75%
|
$430,000
$86.0 P/Share
|
|
Jun 01
2023
|
Karen Lewis Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.71%
|
$170,000
$34.11 P/Share
|
|
May 24
2023
|
Cedric Francois Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
20,000
+2.97%
|
-
|
|
May 24
2023
|
Cedric Francois Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
20,000
-6.79%
|
-
|
|
May 17
2023
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+6.36%
|
$40,000
$2.67 P/Share
|
|
May 17
2023
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
1,250
-0.46%
|
$110,000
$88.66 P/Share
|
|
May 17
2023
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+0.46%
|
$2,500
$2.67 P/Share
|
|
May 16
2023
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,000
-1.7%
|
$2,550,000
$85.43 P/Share
|
|
May 16
2023
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+8.96%
|
$60,000
$2.67 P/Share
|
|
May 08
2023
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,000
-1.15%
|
$1,104,000
$92.39 P/Share
|
|
May 08
2023
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,500
+1.74%
|
$37,000
$2.67 P/Share
|
|
May 03
2023
|
Adam J. Townsend Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-6.17%
|
$410,000
$82.71 P/Share
|
|
May 03
2023
|
Adam J. Townsend Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.81%
|
$75,000
$15.09 P/Share
|
|
May 03
2023
|
Timothy Eugene Sullivan Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
20,000
+26.24%
|
-
|
|
May 03
2023
|
Timothy Eugene Sullivan Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
20,000
-20.47%
|
-
|
|
Apr 27
2023
|
Cedric Francois Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
382,946
+50.0%
|
-
|
|
Apr 27
2023
|
Cedric Francois Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
382,946
-58.23%
|
-
|
|
Apr 21
2023
|
David O. Watson General Counsel |
BUY
Bona fide gift
|
Indirect |
67,955
+50.0%
|
-
|
|
Apr 21
2023
|
David O. Watson General Counsel |
SELL
Bona fide gift
|
Direct |
67,955
-38.84%
|
-
|
|
Apr 19
2023
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.95%
|
$40,000
$2.67 P/Share
|
|
Apr 19
2023
|
Timothy Eugene Sullivan Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
36,232
+50.0%
|
-
|
|
Apr 19
2023
|
Timothy Eugene Sullivan Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
36,232
-27.05%
|
-
|
|
Apr 18
2023
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,000
-4.49%
|
$2,460,000
$82.02 P/Share
|
|
Apr 18
2023
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.3%
|
$60,000
$2.67 P/Share
|
|
Apr 17
2023
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
1,250
-0.46%
|
$101,250
$81.05 P/Share
|
|
Apr 17
2023
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+0.46%
|
$2,500
$2.67 P/Share
|
|
Apr 10
2023
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,000
-1.15%
|
$936,000
$78.21 P/Share
|
|
Apr 10
2023
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,500
+1.75%
|
$37,000
$2.67 P/Share
|
|
Apr 05
2023
|
Cedric Francois Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
26,990
+4.08%
|
-
|
|
Apr 05
2023
|
Cedric Francois Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
26,990
-4.06%
|
-
|
|
Apr 04
2023
|
Cedric Francois Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
380,000
+38.49%
|
-
|
|
Apr 04
2023
|
Cedric Francois Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
380,000
-36.38%
|
-
|
|
Apr 03
2023
|
Cedric Francois Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
227,221
+50.0%
|
-
|
|
Apr 03
2023
|
Cedric Francois Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
227,221
-17.87%
|
-
|
|
Apr 03
2023
|
A. Sinclair Dunlop Director |
SELL
Open market or private sale
|
Direct |
500
-0.38%
|
$37,000
$74.05 P/Share
|
|
Apr 03
2023
|
Adam J. Townsend Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-6.17%
|
$370,000
$74.05 P/Share
|
|
Apr 03
2023
|
Adam J. Townsend Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.81%
|
$75,000
$15.09 P/Share
|
|
Apr 03
2023
|
Karen Lewis Chief People Officer |
SELL
Open market or private sale
|
Direct |
5,000
-10.77%
|
$375,000
$75.0 P/Share
|
|
Apr 03
2023
|
Karen Lewis Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.72%
|
$170,000
$34.11 P/Share
|
|
Mar 22
2023
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
127,221
+3.19%
|
$763,326
$6.76 P/Share
|
|
Mar 21
2023
|
Cedric Francois Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,000
-2.55%
|
$1,860,000
$62.74 P/Share
|
|
Mar 21
2023
|
Cedric Francois Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+2.49%
|
$60,000
$2.67 P/Share
|
|
Mar 17
2023
|
Alec Machiels Director |
SELL
Open market or private sale
|
Direct |
1,250
-0.46%
|
$80,000
$64.03 P/Share
|
|
Mar 17
2023
|
Alec Machiels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+0.46%
|
$2,500
$2.67 P/Share
|
|
Mar 08
2023
|
Pascal Deschatelets Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,000
-1.16%
|
$756,000
$63.79 P/Share
|
|
Mar 08
2023
|
Pascal Deschatelets Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,500
+1.76%
|
$37,000
$2.67 P/Share
|
|
Mar 03
2023
|
Adam J. Townsend Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-6.17%
|
$315,000
$63.84 P/Share
|
|
Mar 03
2023
|
Adam J. Townsend Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.81%
|
$75,000
$15.09 P/Share
|
|
Mar 01
2023
|
A. Sinclair Dunlop Director |
SELL
Open market or private sale
|
Direct |
500
-0.38%
|
$32,500
$65.33 P/Share
|